Digital Therapeutics in Clinical Care: What Providers Need to Know
February 2026
Digital mental health treatments (DMHTs) are recognized as safe and effective evidence-based interventions that help address some of the barriers preventing patients from accessing first-line treatment in a timely manner.
This webinar will focus on best practices for seamlessly integrating DMHTs into a variety of care settings. Common concerns will also be discussed, including apprehension about digital treatments replacing human care, how to tell which tools are evidence-based, and billing and reimbursement models.
Learning objectives
By the end of this webinar, participants can:
Differentiate evidence-based, FDA-cleared DMHTs from wellness products.
Describe different clinical use cases for DMHTs.
Discuss how to integrate DMHTs into their clinical practices.
Presenter disclaimer
Dani Bradley and Alasdair Henry, PhD, have a working relationship with Big Health, and as such, they have a financial and an intellectual interest in the webinar content. The purpose of this presentation is to provide a balanced view on how to integrate digital mental health treatments into your practice.
This program does not offer CE credit.
Paid for by
This topical webinar for APA members is paid for by Big Health. The content was created by Big Health and does not reflect the views of APA or its editorial staff. Email Advertising to learn more. Big Health provides proven care for common mental health conditions delivered through fully digital solutions.
Presenters
Dani Bradley
Dani Bradley is a public health professional and the vice president of clinical affairs at Big Health, a developer of evidence-based digital therapeutics for common mental health conditions. She leads the medical affairs, research, and clinical teams, focusing on demonstrating clinical efficacy and health economics outcomes, as well as working with clinicians to integrate digital treatments into clinical care. Her work has primarily centered on patient-led care, and she is passionate about applying data and scalable solutions to improve health and the patient experience. Dani completed her education at Tufts University, earning an MS and an MPH focused on public health, health care technology, and data analytics.
Henry Alasdair, PhD
Alasdair L. Henry, PhD, is a chartered research psychologist and director of medical affairs at Big Health. He specializes in the scalable treatment of insomnia disorder using digital treatment and oversees clinical research and medical affairs at Big Health. He led the United States Food and Drug Administration clearance of SleepioRx, Big Health’s digital CBT-I treatment for insomnia, and supports expanding access to evidence-based digital mental health treatments. Alasdair has worked in the behavioral medicine field for 14 years and completed his PhD in behavioral medicine at the University of Manchester in the United Kingdom. He was previously an honorary fellow in the Sleep & Circadian Neuroscience Institute at the University of Oxford and is currently an associate fellow of the British Psychological Society.